Testing Therapeutic Proteins for Biological Activity

Testing Therapeutic Proteins for Biological Activity

The potency (biological activity) of a protein-based drug must be demonstrated after the drug is manufactured. This interactive scrollable explains why protein-based drugs must undergo a potency test before being released for patient use, and describes how a biological activity test can be designed to specifically assess the potency of a protein-based drug.

Topics

  • ALXCollab
  • attribute science
  • biologic
  • biological activity
  • dose response
  • drug activity
  • drug concentration
  • drug efficacy
  • drug manufacturing
  • drug potency
  • drug product
  • drug purity
  • drug safety
  • mAb
  • mechanism of action
  • monoclonal antibody
  • new drug batch
  • potency test
  • potency
  • process development
  • protein-based drug
  • protein-based therapeutic
  • reference standard
  • surrogate system
  • target cell
  • test plate
  • therapeutic effect
  • therapeutic protein